Sensyne Health PLC, Anglo Pacific Group PLC, Advanced Oncotherapy PLC, Galantas Gold Corporation PLC…
() told investors it has demonstrated the potential capability and superiority of its LIGHT technology in “biologically enhanced particle therapy” to treat resistant cancers.
(LON:APF, TSX: APY) said it completed the purchase of a 70% net interest in a stream on cobalt production from the Voisey’s Bay mine in Canada for US$205mln (£147mln) in cash. The company, which announced the acquisition last month, may pay a further US$27mln to the private equity sellers.
Galantas Gold Corporation PLC () has re-started underground blasting at the company’s gold mine at Omagh in Northern Ireland.
(), the civil aircraft lessor, has raised £7.5mln to ready itself for the opening up of air travel again post COVID-19.
() said its subsidiary, Modern Water’s MicroTrace PDV 6000ULTRA portable heavy metal analyser, has been nominated for an environmental award in China.
() said it has been advised that the General Court of the European Union has granted to each defendant in the company’s legal action against the European Commission, European Parliament, and Council of the European Union, in relation to their decision to adopt Article 5 of the Single Use Plastics Directive 2019/904, additional time to file their defences. The company said defences must now be filed by April 7 for the Council and Commission and April 14 for the Parliament.
() said it has resolved on a direct share issue without consideration of total of 4,965,265 Afarak’s treasury shares to its South African subsidiary Chromex Mining Company. The share issue is resolved in order to accomplish and execute ownership arrangement in Chromex SA that will result in additional ownership of mining assets in South Africa, the company said, adding that it will benefit the company as the group’s parent company. “Thus, from the company’s point of view especially weighty financial reasons [exist] for the deviation from the shareholders’ pre-emptive right.”
() said it has started searching for a new chief financial officer after Michael Hunt resigned from the company in order to pursue other projects.
() said its dividend in respect of the third quarter of 4.00 US cents per share will, for shareholders who have elected to receive their dividends in sterling, be paid an equivalent payment of 2.85p per share. This is based on the 11 March exchange rate of £0.71358 per US dollar. The dividend will be paid on 26 March 2021 to those shareholders on the register on 5 March.
() announced that it is convening a general meeting of the company’s shareholders at 11.30am on Thursday 8 April 2021, in place of the meeting that had been scheduled to take place on 25 March. The anticipated date of 7 April has been moved back a day because of the Easter bank holidays.
Read More: Sensyne Health PLC, Anglo Pacific Group PLC, Advanced Oncotherapy PLC, Galantas Gold Corporation PLC…